Bain Capital Public Equity Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bain Capital Public Equity Management’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-416,670	Closed	-$4.25M	–	48
2019 Q1	$4.25M	Hold	416,670	–	–	0.41%	41
2018 Q4	$3.13M	Sell	416,670 -321,873	-44%	-$2.36M	0.29%	38
2018 Q3	$7.38M	Sell	738,543 -236,300	-24%	-$2.75M	0.52%	38
2018 Q2	$12.3M	Buy	+974,843	New	+$11.8M	0.83%	26

Other funds holding TBIO

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bain Capital Public Equity Management's TBIO Position: Q2 2019 in Review

Bain Capital Public Equity Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2019, closing a stake of 416,670 shares — an estimated $4.25M sold.

Bain Capital Public Equity Management first reported a position in TBIO in Q2 2018 and held it in 4 quarters. The position peaked at $12.3M in Q2 2018. 60 funds tracked by Wall St. Rank hold TBIO as of Q2 2019.

Bain Capital Public Equity Management reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Bain Capital Public Equity Management sold 416,670 Translate Bio, Inc. Common Stock shares in Q2 2019, an estimated $4.25M.
Bain Capital Public Equity Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
Bain Capital Public Equity Management's Translate Bio, Inc. Common Stock position peaked at $12.3M in Q2 2018.
60 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2019.

Based on Bain Capital Public Equity Management's 13F filing for Q2 2019.